CADL Candel Therapeutics, Inc.

Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.

$3.20  +0.06 (1.91%)
As of 10/03/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/23/2021
Outstanding shares:  28,891,909
Average volume:  23,784
Market cap:   $90,720,594
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BP0TQC5
Valuation   (See tab for details)
PE ratio:   -2.84
PB ratio:   1.44
PS ratio:   731.62
Return on equity:   -51.00%
Net income %:   -26,225.81%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy